Status:
RECRUITING
Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters
Lead Sponsor:
Instituto Valenciano de Infertilidad, IVI VALENCIA
Conditions:
Infertility, Female
ENDOMETRIAL RECEPTIVITY
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
After so many years conducting artificial endometrial preparation cycles for embryo transfer, there is no clear indication about which is the optimal dose of exogenous progesterone in this scenario to...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- All women with no history of infertility who agree to participate in the study:
- Age: 18-35 years old, both inclusive
- Regular menstrual cycles
- In good health and not suffering from any mental or medical condition(s) that would preclude participation in the study.
- Exclusion Criteria
- Subjects who meet one or more of the following will not be considered eligible to participate in the pilot study:
- Simultaneous participation in other clinical studies that, at the researcher's criteria, could interfere with the results of this study.
- Taking oral contraceptives in the three months prior to signing informed consent.
- Presence of uterine pathology (submucosal or intramural myomas \>4 cm deforming cavity, endometrial polyps or müllerian anomalies) or adnexal pathology (communicating hydrosalpinx).
- Background of thrombosis, breast cancer, systemic diseases.
- Those unable to comprehend the investigational nature of the proposed study.
Exclusion
Key Trial Info
Start Date :
December 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04499131
Start Date
December 9 2021
End Date
December 1 2025
Last Update
October 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Valenciano de Infertilidad Spain
Valencia, Valencia, Spain, 46015